West Pharmaceutical Services Inc (WST)
Operating profit margin
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Operating income | US$ in thousands | 569,900 | 676,000 | 734,000 | 752,300 | 406,900 |
| Revenue | US$ in thousands | 2,893,200 | 2,949,800 | 2,886,900 | 2,831,600 | 2,146,900 |
| Operating profit margin | 19.70% | 22.92% | 25.43% | 26.57% | 18.95% |
December 31, 2024 calculation
Operating profit margin = Operating income ÷ Revenue
= $569,900K ÷ $2,893,200K
= 19.70%
West Pharmaceutical Services Inc's operating profit margin has shown a positive trend over the past five years. It stood at 18.95% as of December 31, 2020, and increased steadily to reach 26.57% by December 31, 2021. The margin slightly decreased to 25.43% by the end of 2022 and further declined to 22.92% by December 31, 2023. By the end of December 31, 2024, the operating profit margin was reported at 19.70%.
Overall, the company has maintained a relatively strong operating profit margin during the period under review, with fluctuations in certain years. This indicates that West Pharmaceutical Services Inc has been able to effectively manage its operating expenses relative to its revenue, although a slight downward trend was observed in the most recent year. Further analysis of the company's operational efficiency and cost management practices may provide insights into the factors influencing these fluctuations.
Peer comparison
Dec 31, 2024